Device Dossier
Velosorb Fast Braided Absorbable Suture - Suture, polyglactin
Device Dossier for Velosorb Fast Braided Absorbable Suture - Suture, polyglactin (Suture, polyglactin, Class III, sponsor Medtronic). ARTG record,…
- GMDN category: Suture, polyglactin
Intended purpose
Velosorb™ sutures are indicated for use in soft tissue approximation of the skin and mucosa, where only 7-10 days of wound support is required, but not for use in ligation, ophthalmic, cardiovascular or neurological procedures. Studies indicate tensile strength averages for Velosorb™ suture are approximately 45-55% of its original tensile strength 5 days post implantation. All of the original tensile strength is gone by 14 days. Absorption of Velosorb™ sutures is essentially completed between the 40th and 50th day.
Functional description
Velosorb™ sutures elicit a minimal acute inflammatory reaction in tissue,which is followed by a gradual encapsulation of the suture by fibrous connective tissue.Progressive loss of tensile strength and eventual absorption of Velosorb™ sutures occurs by means of hydrolysis, where the glycolide/lactide copolymer is broken down to glycolic and lactic acids which are subsequently absorbed and metabolized by the body.